Ameritas Investment Partners’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Ameritas Investment Partners’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-178	Closed	-$3K	–	3119
2019 Q1	$3K	Hold	178	–	–	﹤0.01%	2924
2018 Q4	$2K	Hold	178	–	–	﹤0.01%	2964
2018 Q3	$4K	Hold	178	–	–	﹤0.01%	2972
2018 Q2	$8K	Hold	178	–	–	﹤0.01%	2893
2018 Q1	$12K	Hold	178	–	–	﹤0.01%	2665
2017 Q4	$13K	Hold	178	–	–	﹤0.01%	2666
2017 Q3	$13K	Hold	178	–	–	﹤0.01%	2667
2017 Q2	$12K	Hold	178	–	–	﹤0.01%	2762
2017 Q1	$39K	Buy	+178	New	+$25.4K	﹤0.01%	2005

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Ameritas Investment Partners's LUMO Position: Q2 2019 in Review

Ameritas Investment Partners sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2019, closing a stake of 178 shares — an estimated $3K sold.

Ameritas Investment Partners first reported a position in LUMO in Q1 2017 and held it in 9 quarters. The position peaked at $39K in Q1 2017. 68 funds tracked by Wall St. Rank hold LUMO as of Q2 2019.

Ameritas Investment Partners reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Ameritas Investment Partners sold 178 Lumos Pharma, Inc. Common Stock shares in Q2 2019, an estimated $3K.
Ameritas Investment Partners first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2017 and held it in 9 quarters.
Ameritas Investment Partners's Lumos Pharma, Inc. Common Stock position peaked at $39K in Q1 2017.
68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2019.

Based on Ameritas Investment Partners's 13F filing for Q2 2019, filed 14 Aug 2019.